Latest news with #Menitorix
Daily Record
30-06-2025
- Health
- Daily Record
NHS Lanarkshire advising locals UK childhood vaccination schedule is being updated from July 1
Key changes include the removal of the Hib/MenC (Menitorix) vaccine at 12 months. NHS Lanarkshire is advising locals that, from tomorrow, July 1, the UK childhood vaccination schedule is being updated. Key changes include the removal of the Hib/MenC (Menitorix) vaccine at 12 months; adjustments to the timing of MenB and PCV (pneumococcal) vaccines; and the introduction of a new 18-month appointment for a fourth dose of the 6-in-1 vaccine. Download the Lanarkshire Live app today A more detailed breakdown follows below: Phase 1 Changes to the one-year appointment: Hib/MenC (Menitorix): The combined Hib/MenC vaccine, given at the one-year appointment, is being discontinued. MenB and PCV: The second dose of MenB vaccine will be moved from 16 weeks to 12 weeks, while the first dose of PCV vaccine will move from 12 weeks to 16 weeks. Selective Neonatal Hepatitis B programme: The monovalent hepatitis B vaccine dose at one year will be discontinued for children in this program. Phase 2 Introduction of an 18-month appointment from January 1, 2026: A new 18-month appointment will be introduced for a fourth dose of the 6-in-1 vaccine (DTaP/IPV/Hib/HepB). This fourth dose will replace the Hib component of the previously given Hib/MenC vaccine. The second dose of MMR vaccine may be moved from three years, four months to 18 months at this appointment. The rationale for the changes is that the Hib/MenC vaccine is being discontinued because the sole brand, Menitorix, is no longer produced and stocks are being depleted. Adjusting the timing of the MenB and PCV vaccines is intended to provide better protection against MenB during the period when most cases occur (one-to-three months). The fourth 6-in-1 dose at 18 months ensures continued strong immunity to diphtheria, tetanus, pertussis, polio, hepatitis B, and Hib. And moving the second MMR dose to 18 months may improve uptake and reduce measles outbreaks. Parents or carers who have questions about the changes can speak to their health visitor and should continue to attend their vaccination appointment as scheduled.
Scottish Sun
07-05-2025
- Health
- Scottish Sun
Major change to childhood immunisation schedule after concern over surge in killer infection
Plus, everything you need to know about the MMR jab - from whether it's safe to what it's made from JABS UP Major change to childhood immunisation schedule after concern over surge in killer infection HEALTH chiefs have unveiled "significant" changes to the childhood vaccination schedule following a sharp rise in cases of a deadly infection. The age at which children get the MMR jab, which protects against measles, mumps and rubella has been brought forward from three years old to just 18 months. Advertisement 1 It comes after the UK has seen a huge spike in measles cases over the last few years, while vaccine rates have plummeted. Globally, rates of the lethal Victorian disease had doubled in the past year alone. Two doses offer up to 99 per cent protection against measles, mumps and rubella, which can lead to deadly meningitis, hearing loss and problems during pregnancy. Officals from the UK Health Security Agency (UKHSA) hope the move with "improve uptake and provide earlier protection". Advertisement There are four other changes to the jab programme which will "optimise the overall protection of children in the UK", they added. One of the main tweaks is the introduction of a new fourth dose of the 6-in-1 vaccine, given at 18 months. This jab protects against diphtheria, tetanus, whooping cough (also known as pertussis), polio, hepatitis B and Hib - short for haemophilus influenzae type b. Hib is a type of bacteria that can cause life-threatening infections like meningitis and sepsis. Advertisement The change will apply to children turning one on or after July 1, 2025, who will then be offered the extra dose when they hit 18 months. Health officials say the update is needed because the current Hib/Men C vaccine, called Menitorix, which is offered at the one-year mark, is being discontinued due to supply issues. Dr Philippa Kaye urges parents to get their children vaccinated as measles infections surge Despite this, the 12-month appointment will still include the first dose of the MMR vaccine. along with booster shots for meningitis B and pneumococcal disease. Other changes involve the second dose of the meningitis B vaccine being given earlier, at 12 weeks instead of 16. This follows a recent study showing that earlier protection could be more effective. Advertisement To balance this out and avoid too many jabs at one time, the first dose of the pneumococcal vaccine is being moved from 12 weeks to 16 weeks. From January 1, 2026, children turning 18 months will be offered their second MMR jab much earlier than before - at 18 months instead of waiting until three years and four months. However, kids who are already between 18 months and three years four months on January 1, 2026, will stay on the current schedule and get their second MMR dose at the usual time. Changes to routine childhood immunisation schedule From July 2025: The Hib/Men C vaccine (Menitorix) will no longer be given to children turning one. will no longer be given to children turning one. The second meningitis B dose will be moved from 16 weeks to 12 weeks . will be moved from . The first pneumococcal (PCV) dose will be moved from 12 weeks to 16 weeks . will be moved from . The monovalent hepatitis B dose given at one year (for some babies) will be stopped. From January 2026: A new fourth dose of the 6-in-1 vaccine (DTaP/IPV/Hib/HepB) will be introduced at 18 months . of the will be introduced at . The second MMR dose will be moved from 3 years 4 months to 18 months. Latest NHS Digital data shows that in some parts of England, up to three in ten children haven't had both MMR jabs by the time they turn five. Advertisement But the figure needs to be above 90 per cent to stop outbreaks, public health guidance says. Measles mostly produces flu-like symptoms including a fever, a cough, a cold, and a blotchy rash that is usually not itchy. But in some cases, it can travel to other parts of the body, like the lungs or brain, and cause serious illness. Complications include pneumonia, meningitis, blindness, seizures, and death. Advertisement It is transmitted through direct contact with airborne droplets that spread when a person breathes, coughs, or sneezes. It's very unlikely to be measles if you've had both MMR vaccine doses or had measles before. The MMR vaccine is free to everyone on the NHS and is available from GP surgeries. 'Will save the lives of more very young babies' Professor Azeem Majeed, from Imperial College London, told GP magazine Pulse: "The changes to the NHS childhood vaccination programme have important implications for general practices and parents of children in England. Advertisement "For general practices, the guidance requires significant adjustments to vaccination schedules, increased administrative efforts, and proactive communication to ensure compliance and maintain high uptake. "For parents, the changes mean adapting to a new 18-month appointment, understanding the revised schedule based on their child's birth date, and ensuring timely vaccinations." Dr Julie Yates, from UKHSA, added: "Following a review of the latest evidence, the Joint Committee on Vaccination and Immunisation (JCVI) recommended a number of changes to optimise the Childhood Immunisation programme and increase overall protection of children in the UK. "With the UK close to seeing an end to Meningitis C circulating, JCVI advised that a vaccination is no longer required for infants due to the excellent population protection provided by the adolescent Meningitis ACWY programme. Advertisement "Other changes, such as the bringing forward of the Meningitis B vaccine are based on evidence that will save the lives of more very young babies."
